Russia's Pharmsynthez raises $17 million in IPO in Moscow
This article was originally published in Scrip
Executive Summary
Russia's Pharmsynthez has raised Rb528 million ($17 million) in an IPO conducted on the market for innovations and investments of Moscow Interbank Currency Exchange (MICEX). On 1 December, the shares also began trading under the same LIFE ticker without an additional listing on the Russian Trading System Stock Exchange (RTS).